MML Investors Services LLC Increases Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

MML Investors Services LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 22,684 shares of the company’s stock after purchasing an additional 1,062 shares during the period. MML Investors Services LLC’s holdings in GE HealthCare Technologies were worth $2,129,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in GEHC. iA Global Asset Management Inc. increased its position in GE HealthCare Technologies by 3.8% during the 3rd quarter. iA Global Asset Management Inc. now owns 46,551 shares of the company’s stock valued at $4,369,000 after buying an additional 1,710 shares in the last quarter. EP Wealth Advisors LLC grew its stake in shares of GE HealthCare Technologies by 25.7% in the third quarter. EP Wealth Advisors LLC now owns 8,278 shares of the company’s stock worth $777,000 after acquiring an additional 1,691 shares during the last quarter. Insigneo Advisory Services LLC increased its holdings in shares of GE HealthCare Technologies by 14.3% during the third quarter. Insigneo Advisory Services LLC now owns 7,453 shares of the company’s stock valued at $699,000 after acquiring an additional 934 shares in the last quarter. Kovitz Investment Group Partners LLC raised its position in shares of GE HealthCare Technologies by 3.1% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 71,815 shares of the company’s stock worth $6,359,000 after purchasing an additional 2,193 shares during the last quarter. Finally, Wahed Invest LLC boosted its stake in GE HealthCare Technologies by 12.0% in the 3rd quarter. Wahed Invest LLC now owns 10,716 shares of the company’s stock worth $1,006,000 after purchasing an additional 1,149 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on GEHC. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.46.

GE HealthCare Technologies Stock Performance

GEHC opened at $80.29 on Tuesday. The company’s 50 day moving average is $85.64 and its 200 day moving average is $83.79. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a market cap of $36.68 billion, a price-to-earnings ratio of 22.06, a PEG ratio of 2.96 and a beta of 1.07. GE HealthCare Technologies Inc. has a 12-month low of $71.31 and a 12-month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s revenue was up .9% compared to the same quarter last year. During the same quarter last year, the company posted $0.99 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.